Calpain-2 can downregulate DNA damage signaling proteins, such as TP53 and TP53BP1, to block DNA damage recognition and active NF-κB signaling to inhibit the sensitivity of GBM cells to TMZ [122]. The gene discussed is NFKB1; the disease is glioblastoma.